advertisement
Inoue T 15
Showing records 1 to 15 | Display all abstracts from Inoue T61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Tanihara H
JAMA ophthalmology 2015; 133: 755-761
61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Ohira S
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548
61148 Elevated intraocular pressure induces Rho GTPase mediated contractile signaling in the trabecular meshwork
Pattabiraman PP
Experimental Eye Research 2015; 136: 29-33
61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Inoue T
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Inoue T
JAMA ophthalmology 2015; 133: 755-761
61148 Elevated intraocular pressure induces Rho GTPase mediated contractile signaling in the trabecular meshwork
Inoue T; Rao PV
Experimental Eye Research 2015; 136: 29-33
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Yamamoto T
JAMA ophthalmology 2015; 133: 755-761
61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Shobayashi K
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Kuwayama Y
JAMA ophthalmology 2015; 133: 755-761
61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Iwao K
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Abe H
JAMA ophthalmology 2015; 133: 755-761
61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Fukushima M
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Suganami H
JAMA ophthalmology 2015; 133: 755-761
61057 Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection
Tanihara H
Investigative Ophthalmology and Visual Science 2015; 56: 3541-3548
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Araie M;
JAMA ophthalmology 2015; 133: 755-761
